跳至主要内容
临床试验/JPRN-UMIN000003291
JPRN-UMIN000003291已完成3 期

Occlusive/Stenotic Peripheral artery REvascularization study - OSPREY

Terumo Corporation0 个研究点目标入组 100 人开始时间: 2010年3月5日最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Terminal illness in whom life expectancy is expected to be less than 3 years. (2) Patients who are participating in other clinical study of medical device or pharmaceuticals within 3months before registration. (3) Already participated in this study in the past. (4) Previously received a bypass surgery, stent implantation or any surgery at SFA or distally. (5) Scheduled for a staged procedure to treat lesions within the aorta or ipsilateral run-off vessels after enrollment. (6) Allergy or experienced an anaphylactic symptom to components of the study device. (7) Acute or chronic renal failure (serum creatinine 2.0mg/dL or more) (8) Advanced calcification or excessive tortuosity at target lesion (9) Patients who are pregnant or breast-feeding, or in whom these conditions are possible. (10) Patients who were judged to be inappropriate for participation in the study due to severe or uncontrolled systemic disease of any condition by the principal investigators/investigators.

研究者

相似试验